| |
| |
|
| Insider
Information: |
Sheridan William P |
| Relationship: |
Chief Medical Officer |
| City: |
Birmingham |
| State: |
AL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
37,954 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$239,490 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
37,954 |
|
|
| Total
Value |
$239,490 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -20.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
Chief Medical Officer |
2022-03-10 |
37,954 |
2009-01-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2021-05-27 |
4 |
AS |
$15.00 |
$1,076,385 |
D/D |
(71,759) |
14,475 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2021-05-27 |
4 |
OE |
$4.73 |
$378,114 |
D/D |
71,759 |
86,234 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2021-05-28 |
4 |
AS |
$15.02 |
$1,379,046 |
D/D |
(91,814) |
14,475 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2021-05-28 |
4 |
OE |
$4.73 |
$493,826 |
D/D |
91,814 |
106,289 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2021-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
50,791 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2022-03-10 |
4 |
OE |
$3.22 |
$477,532 |
D/D |
148,302 |
199,093 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Medical Officer |
• • – |
2022-03-10 |
4 |
S |
$16.87 |
$2,719,493 |
D/D |
(161,139) |
37,954 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2014-03-01 |
4 |
D |
$11.69 |
$20,329 |
D/D |
(1,739) |
137,122 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2014-06-03 |
4 |
D |
$9.86 |
$100,345 |
D/D |
(10,177) |
148,173 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2014-06-03 |
4 |
OE |
$4.15 |
$100,333 |
D/D |
21,228 |
149,817 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2014-12-29 |
4 |
S |
$12.43 |
$1,308,817 |
D/D |
(105,295) |
92,518 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2014-12-29 |
4 |
OE |
$1.42 |
$205,742 |
D/D |
48,396 |
197,813 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2014-12-30 |
4 |
S |
$12.06 |
$278,634 |
D/D |
(23,104) |
92,518 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2014-12-30 |
4 |
OE |
$1.42 |
$32,808 |
D/D |
23,104 |
115,622 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2015-01-01 |
4 |
D |
$12.16 |
$33,258 |
D/D |
(2,735) |
100,683 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2015-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,900 |
103,418 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2015-01-20 |
4 |
D |
$11.17 |
$56,677 |
D/D |
(5,074) |
95,609 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2015-03-01 |
4 |
D |
$10.20 |
$17,738 |
D/D |
(1,739) |
95,123 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2015-06-19 |
4 |
AS |
$15.05 |
$1,059,354 |
D/D |
(70,389) |
95,123 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2015-06-19 |
4 |
OE |
$1.20 |
$84,467 |
D/D |
70,389 |
165,512 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2016-01-01 |
4 |
D |
$10.32 |
$21,476 |
D/D |
(2,081) |
94,326 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2016-01-20 |
4 |
D |
$7.55 |
$40,460 |
D/D |
(5,359) |
88,967 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2016-03-01 |
4 |
D |
$2.13 |
$1,702 |
D/D |
(799) |
90,052 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2017-01-01 |
4 |
D |
$6.33 |
$13,173 |
D/D |
(2,081) |
88,677 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP - CMO |
• • – |
2017-01-20 |
4 |
D |
$5.95 |
$34,278 |
D/D |
(5,761) |
82,916 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
